Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Gynecologic 1

Conditions

Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Pain 1Neoplasms 1

Interventions

Analgesia 4Psychiatric Rehabilitation 2Paclitaxel 2Fentanyl 2Behavior Therapy 2Zolpidem 1Uncertainty 1Taxes 1Sugars 1Ropivacaine 1Psychosocial Intervention 1Palliative Care 1Omacor 1Nutritional Support 1Naproxen 1Methods 1Massage 1Ketorolac Tromethamine 1Ketorolac 1Hydromorphone 1Glutathione 1Fish Oils 1Fatty Acids, Omega-3 1Early Intervention, Educational 1D-methadone 1Cognitive Behavioral Therapy 1Celecoxib 1Carboplatin 1Acupuncture Therapy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × Ketorolac Tromethamine × Gynecologic × Clear all
NCT01670799 2020-02-27

Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer

New Mexico Cancer Research Alliance

Phase EARLY_PHASE1 Completed
29 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡